61475 20190220220209.0 doi 10.1056/NEJMc1308259 sideral 83195 ART-2013-83195 eng Grzybowski, A. Antithrombotic therapy and invasive procedures [5] 2013 Access copy available to the general public Unrestricted To the Editor: Baron et al. (May 30 issue) make important suggestions in their review article; however, we propose that quantitative assessment of iatrogenic bleeding hazards must be considered as well as thrombosis prevention. Although CHA2DS2–VASc scoring for atrial fibrillation is mentioned, the Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly (HAS-BLED) score for bleeding has also been validated. Both scores calculate estimated annual risks and benefits and hence can guide future therapy... info:eu-repo/semantics/openAccess All rights reserved http://www.europeana.eu/rights/rr-f/ 54.42 2013 MEDICINE, GENERAL & INTERNAL 1 / 155 = 0.006 2013 Q1 T1 info:eu-repo/semantics/other info:eu-repo/semantics/publishedVersion (orcid)0000-0001-9876-5850 Ascaso, F.J. Universidad de Zaragoza 1004 646 Universidad de Zaragoza Departamento de Cirugía, Ginecología y Obstetricia Oftalmología 369, 11 (2013), 1077-1080 N. Engl. j. med. NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 322823 http://zaguan.unizar.es/record/61475/files/texto_completo.pdf Versión publicada 109621 http://zaguan.unizar.es/record/61475/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:61475 articulos driver 2017-06-12-09:39:12 ARTICLE